Rising Focus on Developing Erythropoietin Biosimilars in Europe

“To combat rising healthcare expenditure the European countries are focusing on developing EPO biosmilars” says RNCOS

Biosimilars are biopharmaceutical drugs that are designed to have properties, which are similar to the ones of biologic drugs. The biosimilars have no clinically meaningful differences from the reference product.

According to a new report published by RNCOS, named, “European Erythropoietin Market Outlook 2022”, since the year of their introduction, the EPO biosimilars have gained a lot of popularity. The biologics are more complex and costly to develop, whereas the biosimilars being the generic version of these biologics are a cost-effective alternative to these high priced drugs. The biosimilars cost about 25% less than the innovator drug, due to the reduced clinical trials. This results in higher adoption rate of these biosimilar drugs as compared to innovators. This reason is also compelling high number of pharmaceutical companies in Europe to create a strong pipeline of innovative EPO biosimilars.

Currently, several EPO biosimilars are in various stages of clinical development. Some of them are HX575 and HX 575 s.c., amongst others. The pharmaceutical companies in Europe that are developing a strong pipeline of erythropoietin biosimilars include Novartis and Roche amongst others.

Researchers are also engaged in developing the fourth generation of erythropoietin. The fourth generation EPOs is being developed by making use of adenovirus, which contains a piece of erythropoietin-DNA, from humans, genetically incorporated into it. Once these erythropoietin biosimilars enter the European market, they are going to strongly drive the growth of the European erythropoietin market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM863.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


Contact Details

Company Name: RNCOS E-Services Pvt. Ltd.
Issued By: Shushmul Maheshwari
Phone: 1204224700
Address: G-199 Sector 63
City: Noida
State: Uttar Pradesh
Zip: 201301
Country: India
Website: Visit the website

Keywords : European Erythropoietin Market, European Erythropoietin Market research, european erythropoietin market analysis, european erythropoietin market trends, european erythropoietin market forecast,

by Shushmul Maheshwari (few years ago!)

Latest Press Releases

The Mad Hatter Now Offer a Full Line of Hearth Products and Full Line of Grills

Diabetes Insulin Delivery Pens Market Research Report 2018

Dr Kapadia Provides Tips to Patients Interested in Hair Transplant Procedures

love vashikaran specialist

Solar Blanket Sales Market Report 2018

Spring Bottled Water Market Insights, Forecast to 2025

Biochemical Incubator Sales Market Report 2018

Quinine Sulphate Sales Market Report 2018

Automotive Chassisc System Market Insights, Forecast to 2025

2,6-Dicarboxypyridine market size in key regions like North America, Europe, Asia Pacific an..

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.